Search
Element Search
Structure Search
Thermo Scientific Chemicals
4-Acetylbutyric acid, 97%
CAS: 3128-06-1 | C6H10O3 | 130.14 g/mol
Have Questions?
Change view
Catalog number L03978.06
also known as L03978-06
Price (EUR)
42,65
キャンペーン価格
47,00Save 4,35 (9%)
Each
Quantity:
5 g
Price (EUR)
42,65
キャンペーン価格
47,00Save 4,35 (9%)
Each
Chemical Identifiers
CAS3128-06-1
IUPAC Name5-oxohexanoic acid
Molecular FormulaC6H10O3
InChI KeyMGTZCLMLSSAXLD-UHFFFAOYSA-N
SMILESCC(=O)CCCC(O)=O
View more
Specifications
Specification Sheet
Specification SheetAssay (Aqueous acid-base Titration)≥96.0 to ≤104.0%
Refractive Index1.4430-1.4480 @ 20?C
Appearance (Color)Clear colorless to yellow or brown
Assay (GC)≥96.0%
FormLiquid
4-Acetylbutyric acid is used in the synthesis of selective indomethacin analogues for AKR1C3 inhibition in the treatment of castrate-resistant prostate cancer. It is also used to prepare PARP inhibitors for the treatment of cancer.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
4-Acetylbutyric acid is used in the synthesis of selective indomethacin analogues for AKR1C3 inhibition in the treatment of castrate-resistant prostate cancer. It is also used to prepare PARP inhibitors for the treatment of cancer.
Solubility
Slightly soluble in water, chloroform and methanol.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Incompatible with oxidizing agents.
4-Acetylbutyric acid is used in the synthesis of selective indomethacin analogues for AKR1C3 inhibition in the treatment of castrate-resistant prostate cancer. It is also used to prepare PARP inhibitors for the treatment of cancer.
Solubility
Slightly soluble in water, chloroform and methanol.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Incompatible with oxidizing agents.
RUO – Research Use Only
Andy J. Liedtke; Adegoke O. Adenij; Mo Chen; Michael C. Byrns; Yi Jin; David W. Christianson; Lawrence J. Marnett and Trevor M. Penning. Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer.J. Med. Chem.2013, 56 (6), 2429-2446.